Biological validation of differetially expressed genes in chronic lymphocytic leukemia identified by applying multiple statistical methods to oligonucleotide microarrays

Journal of Molecular Diagnostics

Volumn 7, Issue 3, 2005, Pages 337-345

  Abruzzo, Lynne V ^a   Wang, Jing ^a   Kapoor, Mini ^a   Medeiros, L Jeffrey ^a   Keating, Michael J ^a   Highsmith, W Edward ^b   Barron, Lynn L ^a   Cromwell, Candy C ^a   Coombes, Kevin R ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; TUMOR PROTEIN;

ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DNA HYBRIDIZATION; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; HUMAN; NONPARAMETRIC TEST; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STUDENT T TEST; VALIDATION PROCESS; ALGORITHM; BIOLOGICAL MODEL; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOGLOBULIN VARIABLE REGION; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOMATIC HYPERMUTATION; STATISTICAL MODEL;

ALGORITHMS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; LEUKEMIA, LYMPHOCYTIC, CHRONIC; MODELS, GENETIC; MODELS, STATISTICAL; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN;

EID: 23844435566     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-1578(10)60562-4     Document Type: Article

References (27)

1. Li C, Wong WH. Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application, Genome Biol 2001, 2:research0032.1-research0032.11
2. Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL, Buchbinder A, Budman D, Dittmar K, Kolitz J, Lichtman SM, Schulman P, Vinciguerra VP, Rai KR, Ferrarini M, Chiorazzi N: Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999, 94:1840-1847
3. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK: Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999, 15:1848-1854
4. McCarthy H, Wierda WG, Barron LL, Cromwell CC, Wang J, Coombes KR, Rangel R, Elenitoba-Johnson KSJ, Keating MJ, Abruzzo LV: High expression of activation-induced cytidine deaminase (AID) and splice variants is a distinctive feature of poor prognosis chronic lymphocytic leukemia. Blood 2003, 101:4903-4908
5. Gold D, Coombes K, Medhane D, Ramaswamy A, Ju Z, Strong L, Koo JS, Kapoor M: A comparative analysis of data generated using two different target preparation methods for hybridization to high-density oligonucleotide microarrays. BMC Genomics 2004, 5:2
6. Li C, Wang WH: Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci USA 2001, 98:31-36
7. Pounds S, Morris SW: Estimating the occurrence of false positives and false negatives in microarray studies by approximating and partitioning the empirical distribution of p-values. Bioinformatics 2003, 19:1236-1242
8. Benjamini Y, Hochberg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B 1995, 57:289-300
9. Efron B, Tibshirani R: Empirical bayes methods and false discovery rates for microarrays. Genet Epidemiol 2002, 23:70-86
10. Li C, Wong WH: DNA-Chip Analyzer (dChip). The analysis of gene expression data: methods and software. Edited by G Parmigiani, ES Garrett, R Irizarry, SL Zeger. New York, Springer-Verlag, 2003, pp 120-141
11. Korz C, Pscherer A, Benner A, Mertens D, Schaffner C, Leupolt E, Dohner H, Stilgenbauer S, Lichter P: Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genes. Blood 2002, 99:4554-4561
12. Carpentieri U, Monahan TM, Gustavson LP: Observations on the level of cyclic nucleotides in three population of human lymphocytes in culture. J Cyclic Nucleotide Res 1980, 6:253-259
13. Carlucci F, Tabucchi A, Pagani R, Marinello E: Synthesis of adenine and guanine nucleotides at the 'inosinic branch point' in lymphocytes of leukemia patients. Biochim Biophys Acta 1999, 1454:106-114
14. Eisen MB, Spellman PT, Brown PO, Botstein D: Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998, 95:14863-14868
15. Rocke DM, Durbin B: A model for measurement error for gene expression arrays. J Comput Biol 2001, 8:557-569
16. Durbin BP, Hardin JS, Hawkins DM, Rocke DM: A variance-stabilizing transformation for gene-expression microarray data. Bioinformatics 2002, 18 (Suppl 1):S105-S110
17. Geller SC, Gregg JP, Hagerman P, Rocke DM: Transformation and normalization of oligonucleotide microarray data. Bioinformatics 2003, 19:1817-1823
18. Baggerly KA, Coombes KR, Hess KR, Stivers DN, Abruzzo LV, Zhang W: Identifying differentially expressed genes in cDNA microarray experiments. J Comput Biol 2001, 8:639-659
19. Cuomo CA, Kirch SA, Gyuris J, Brent R, Oettinger MA: Rch1, a protein that specifically interacts with the RAG-1 recombination-activating protein. Proc Natl Acad Sci USA 1994, 91:6156-6160
20. Kovac CR, Emelyanov A, Singh M, Ashouian N, Birshtein BK: BSAP (Pax5)-importin alpha 1 (Rch1) interaction identifies a nuclear localization sequence. J Biol Chem 2000, 275:16752-16757
21. Zaru A, Cameron TO, Stern LJ, Muller S, Valitutti s: TCR engagement and triggering in the absence of large-scale molecular segregation at the T cell-APC contact site. J Immunol 2002, 168:4287-4291
22. Kampalath B, Barcos MP, Stewart C: Phenotypic heterogeneity of B cells in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. Am J Clin Pathol 2003, 119:824-832
23. Manie SN, Beck AR, Astier A, Law SF, Canty T, Hirai H, Druker BJ, Avraham H, Haghayeghi N, Sattler M, Salgia R, Griffin JD, Golemis EA, Freedman AS: Involvement of p130(Cas) and p105(HEF1), a novel Cas-like docking protein, in a cytoskeleton-dependent signaling pathway initiated by ligation of integrin or antigen receptor on human B cells. J Biol Chem 1997, 272:4230-4236
24. Zhang W, Mi J, Li N, Sui L, Wan T, Zhang J, Chen T, Cao X: Identification and characterization of DPZF, a novel human BTB/POZ zinc finger protein sharing homology to BCL-6. Biochem Biophys Res Commun 2001, 282:1067-1073
25. Hamblin TJ, Orchard JA, Ibbotson RE, Davis Z, Thomas PW, Stevenson FK, Oscier DG: CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood 2002, 99:1023-1029
26. Chen L, Widhopf G, Huynh L, Rassenti L, Rai KR, Weiss A, Kipps TJ: Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia. Blood 2002, 100:4609-4614
27. Wiestner A, Rosenwald A, Barry TS, Wright G, Davis RE, Henrickson SE, Zhao H, Ibbotson RE, Orchard JA, Davis Z, Stetler-Stevenson M, Raffeld M, Arthur DC, Marti GE, Wilson WH, Hamblin TJ, Oscier DG, Staudt LM: ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood 2003, 101:4944-4951